GSA Capital Partners’s Zymeworks ZYME Stock Holding History

GSA Capital Partners’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$514K	Buy	+20,511	New	+$485K	0.03%	901
2023 Q2	–	Sell	-37,093	Closed	-$335K	–	2004
2023 Q1	$335K	Buy	37,093 +9,230	+33%	+$80.5K	0.03%	958
2022 Q4	$219K	Buy	+27,863	New	+$196K	0.03%	1132
2022 Q2	–	Sell	-46,149	Closed	-$302K	–	1868
2022 Q1	$302K	Buy	46,149 +31,652	+218%	+$282K	0.04%	886
2021 Q4	$238K	Sell	14,497 -35,504	-71%	-$740K	0.03%	1101
2021 Q3	$1.45M	Buy	+50,001	New	+$1.66M	0.15%	139

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GSA Capital Partners's ZYME Position: Q1 2026 in Review

GSA Capital Partners opened a new position in Zymeworks (ZYME) in Q1 2026: 20,511 shares worth $514K. The stake represents 0.03% of the portfolio and ranks #901 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in ZYME as recently as Q1 2023.

GSA Capital Partners first reported a position in ZYME in Q3 2021 and has held it in 6 quarters since. The position peaked at $1.45M in Q3 2021. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

GSA Capital Partners held 20,511 shares of Zymeworks worth $514K as of Q1 2026.
Zymeworks was a new GSA Capital Partners position in Q1 2026.
Zymeworks made up 0.03% of GSA Capital Partners's portfolio in Q1 2026, its #901 holding.
GSA Capital Partners first reported a position in Zymeworks in Q3 2021 and has held it in 6 quarters since.
GSA Capital Partners's Zymeworks position peaked at $1.45M in Q3 2021.
211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.